Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander T Sandhu

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
JACC. Heart Failure|September 25, 2025
Recalibrating Our Understanding of Meaningful Health Status Change in Heart FailureAlexander T Sandhu
JACC. Heart Failure|September 22, 2023
Lifting the Veil on Advanced Heart FailureAlexander T Sandhu, Rohan Khera
JACC. Heart Failure|July 6, 2024
Sodium-Glucose Cotransporter Inhibitors in Heart Failure: Access, Economics, and Clinical PromiseAlexander T Sandhu, Jimmy Zheng
Journal of the American College of Cardiology|May 24, 2023
The Inflation Reduction Act Expands Prescription Drug Affordability: Decades in the MakingJimmy Zheng, Alexander T Sandhu
Journal of the American College of Cardiology|May 27, 2026
12 Is the New 23: Health Status Assessment in Heart Failure TrialsAlexander T Sandhu, Elena Vasti
Journal of the American College of Cardiology|July 15, 2017
Using Commercial Programs for Lifestyle Intervention: Not Reinventing the WheelDavid J Maron, Alexander T Sandhu
Circulation|June 28, 2021
High-Deductible Health Plans and Emergency Care for Chest Pain: To Go or Not to GoNeil M Kalwani, Alexander T Sandhu
Circulation|March 15, 2021
The Affordability of Guideline-Directed Medical Therapy: Cost Sharing is a Critical Barrier to Therapy AdoptionAlexander T Sandhu, Paul A Heidenreich
The New England Journal of Medicine|January 18, 2019
Coronary CT Angiography and Subsequent Risk of Myocardial InfarctionAlexander T Sandhu, David J Maron
JAMA Cardiology|March 4, 2023
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure and Preserved Ejection Fraction-Living on the EdgeAlexander T Sandhu, David J Cohen
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
JACC. Heart Failure|September 25, 2025
Recalibrating Our Understanding of Meaningful Health Status Change in Heart FailureAlexander T Sandhu
JACC. Heart Failure|September 22, 2023
Lifting the Veil on Advanced Heart FailureAlexander T Sandhu, Rohan Khera
JACC. Heart Failure|July 6, 2024
Sodium-Glucose Cotransporter Inhibitors in Heart Failure: Access, Economics, and Clinical PromiseAlexander T Sandhu, Jimmy Zheng
Journal of the American College of Cardiology|May 24, 2023
The Inflation Reduction Act Expands Prescription Drug Affordability: Decades in the MakingJimmy Zheng, Alexander T Sandhu
Journal of the American College of Cardiology|May 27, 2026
12 Is the New 23: Health Status Assessment in Heart Failure TrialsAlexander T Sandhu, Elena Vasti
Journal of the American College of Cardiology|July 15, 2017
Using Commercial Programs for Lifestyle Intervention: Not Reinventing the WheelDavid J Maron, Alexander T Sandhu
Circulation|June 28, 2021
High-Deductible Health Plans and Emergency Care for Chest Pain: To Go or Not to GoNeil M Kalwani, Alexander T Sandhu
Circulation|March 15, 2021
The Affordability of Guideline-Directed Medical Therapy: Cost Sharing is a Critical Barrier to Therapy AdoptionAlexander T Sandhu, Paul A Heidenreich
The New England Journal of Medicine|January 18, 2019
Coronary CT Angiography and Subsequent Risk of Myocardial InfarctionAlexander T Sandhu, David J Maron
JAMA Cardiology|March 4, 2023
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure and Preserved Ejection Fraction-Living on the EdgeAlexander T Sandhu, David J Cohen
Pageof 14